Curesponse
Curesponse is a medical company developing a three-dimensional tissue culture system for modeling cancer growth and drug response.
Curesponse has raised €5.5M across 1 funding round, most recently a Series A round in May 2020. Based in Tel Aviv, Israel; founded 2018; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€5.5M
€5,533,524
Funding rounds
1
Investors
0
distinct backers
Active since
2020-05
latest 2020-05
Funding by year
EUR raised per yearCuresponse — funding by year — interactive chart.
Data table
| Curesponse — funding by year | |
|---|---|
| 2020 | €5.5M |
Signals
Medium confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-05-06 | Series A | €5.5M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Trax€789MIsrael · Software
Global coverage: FundingData